|1.||Neutel, Joel M: 27 articles (09/2014 - 01/2002)|
|2.||Bakris, George L: 20 articles (02/2013 - 12/2003)|
|3.||Turner, Stephen T: 17 articles (06/2015 - 03/2002)|
|4.||Boerwinkle, Eric: 17 articles (06/2015 - 03/2002)|
|5.||Weber, Michael A: 17 articles (07/2013 - 04/2003)|
|6.||Chapman, Arlene B: 16 articles (06/2015 - 03/2002)|
|7.||Oparil, Suzanne: 14 articles (03/2014 - 01/2005)|
|8.||Schmieder, Roland E: 13 articles (01/2015 - 12/2002)|
|9.||Kereiakes, Dean J: 13 articles (01/2014 - 01/2007)|
|10.||Chrysant, Steven G: 13 articles (01/2014 - 09/2003)|
|1.||Hypertension (High Blood Pressure)
11/01/2010 - "Study results demonstrate that OM ± hydrochlorothiazide is highly effective in reducing BP while enabling a majority of patients with stage 1 hypertension to achieve BP goal. "
11/01/2009 - "Aml 10 mg/Val 320 mg/HCTZ 25 mg triple therapy is highly effective in reducing BP compared with dual components early in therapy, and systolic BP-lowering effects were proportionate to hypertension severity."
10/01/2012 - "Adding HCTZ to a range of OLM/AML dose combinations is well tolerated and improved BP control by significantly lowering DBP and SBP and significantly increasing BP threshold achievement in patients with moderate-to-severe hypertension. "
01/01/2015 - "The aim of this MAPPY study sub-analysis was to determine whether Los/HCTZ was effective for controlling isolated morning hypertension (morning BP ≥ 135/85 mmHg and evening BP < 135/85 mmHg), sustained hypertension (morning and evening BP ≥ 135/85 mmHg), or both. "
07/01/2013 - "Direct and indirect evidence demonstrates that CTDN is superior to HCTZ in reducing CVEs and is congruent with the recent changes in the guidelines for hypertension management."
08/01/2011 - "Our results suggest that low dose (0.5 mg/kg/day) of hydrochlorothiazide may be safe and effective in controlling renal hypercalciuria in children."
12/01/2013 - "Since hydrochlorothiazide ameliorates hypercalciuria, we assessed its efficacy in preventing recurrent UTIs in hypercalciuric girls. "
01/01/2012 - "Low-dose or high-dose hydrochlorothiazide in idiopathic hypercalciuria among children? "
08/01/2011 - "To evaluate the therapeutic effect of hydrochlorothiazide in idiopathic renal hypercalciuria. "
07/01/1999 - "After two years on continuous treatment with hydrochlorothiazide, hypercalciuria decreased without deterioration of renal function. "
04/01/2015 - "After the addition of HCTZ therapy, systolic and diastolic blood pressures (S-BP, D-BP) as well as proteinuria significantly decreased (S-BP: at 6 months, p < 0.05 and 12 months, p < 0.01 vs. 0 month, D-BP: at 12 months, p < 0.05 vs. 0 month, proteinuria: at 6 months, p < 0.05 and 12 months, p < 0.01 vs. 0 month). "
04/01/2015 - "We examined clinical parameters including blood pressure (BP), proteinuria, and eGFR before and after the addition of HCTZ. "
07/01/1998 - "Interestingly, addition of hydrochlorothiazide again reduced proteinuria to 2.8 (0.6-5.8) g/day (P < 0.05). "
10/15/1961 - "[Action of hydrochlorothiazide on nephrotic proteinuria]."
05/01/2008 - "Therefore, this randomized, double-blind, placebo-controlled trial to determine the separate and combined effects of a low-sodium diet and hydrochlorothiazide (HCT) on proteinuria and BP was performed. "
11/11/1985 - "These sex-related changes in lipid fractions occurring with HCTZ treatment, if they occur in humans, may contribute to sex-related differences in rates and severity of atherosclerosis in HCTZ-treated populations."
04/01/1995 - "A large study, the Multicentre Isradipine Diuretic Atherosclerosis Study (MIDAS), was designed to compare the efficacy of isradipine and hydrochlorothiazide in reducing the rate of progression of carotid artery wall thickness, measured by B-mode ultrasound, as a surrogate for early atherosclerosis. "
01/01/1990 - "The Multicenter Isradipine/Diuretic Atherosclerosis Study (MIDAS) is a clinical trial to compare the efficacy of isradipine (2.5-5.0 mg b.i.d.) and hydrochlorothiazide (12.5-25 mg b.i.d.) in retarding atherosclerosis in carotid arteries. "
03/15/2002 - "In the present study, we compared the effects of eprosartan, an AT(1) receptor inhibitor, with the diuretic hydrochlorothiazide in a group of newly diagnosed hypertensive patients with multiple risk factors for atherosclerosis. "
04/17/1989 - "The Multicenter Isradipine Diuretic Atherosclerosis Study is a randomized, double-blind, clinical trial designed to compare the effectiveness of isradipine against hydrochlorothiazide in retarding the rate of progression of atherosclerotic lesions in the carotid arteries of hypertensive subjects. "
01/01/2010 - "Selective chloride loading is pressor in the stroke-prone spontaneously hypertensive rat despite hydrochlorothiazide-induced natriuresis."
01/01/2007 - "In Ve + Tr compared to At + HCTZ patients, adjusted risk for PO (hazard ratio [HR] 0.63; 95% CI 0.37, 1.05; p = 0.07) and unadjusted risks for secondary outcomes including death (HR 0.70; 95% CI 0.40, 1.25), total MI (HR 0.82; 95% CI 0.35, 1.90), total stroke (HR 0.81; 95% CI 0.25, 2.65) and new diabetes (HR 0.88; 95% CI 0.55, 1.41) were not statistically different. "
10/01/2011 - "However, there is no evidence that HCTZ in its usual dose of 12.5-25 mg daily reduces myocardial infarction, stroke, or death. "
05/01/1993 - "In contrast, hydrochlorothiazide improved ventricular compliance (strain versus LVEDP, slope of 2K1C versus 2K1C hydrochlorothiazide, p < 0.01) and thus returned the stroke work versus LVEDP relation to sham values (intercept of 2K1C versus 2K1C hydrochlorothiazide, p < 0.001). "
01/01/2015 - "The aim of this study was to elucidate whether hydrochlorothiazide additionally exerts such effects in stroke patients under treatment with losartan. "
|10.||olmesartan medoxomil (Votum)
|1.||Drug Therapy (Chemotherapy)
|3.||Lithotripsy (Extracorporeal Shockwave Lithotripsy)
|5.||Sodium-Restricted Diet (Diet, Sodium Restricted)